New Finding Points to Potential Options for Attacking Stem Cells in Triple-Negative Breast Cancer
New research finds that a protein that fuels an inflammatory pathway does not turn off in breast cancer, resulting in an increase in cancer stem cells. This provides a potential target for treating triple negative breast cancer, the most aggressive form of the disease. [Press release from the University of Michigan Health System discussing online prepublication in Oncogene]
Press Release|Abstract
HER2 in Breast Cancer: A Review and Update
The aim of this review on human epidermal growth factor receptor 2 (HER2) in breast cancer is to discuss the important aspects of HER2 biology, its significance in breast cancer, and the current standards for its detection. [Adv Anat Pathol]
Abstract
Visit our reviews page to see a complete list of reviews in the mammary cell research field.
AAAS Launches Open-Access Journal
Joining a herd of other scientific societies, the American Association for the Advancement of Science (AAAS) announced that it will launch the organization’s first online, fully open-access journal early next year. The new journal, called Science Advances, will give authors another outlet for papers that they are willing to pay to make immediately free to the public. [ScienceInsider]
Editorial
Recruit Top Talent: Reach more than 50,000 potential candidates by posting
your organization’s career opportunities on the Connexon Creative Job Board at no cost.
Have we missed an important article or publication in Mammary Cell News? Click here to submit!
Comments or Suggestions? Submit your feedback here.